iBio, Inc. financial data

Symbol
IBIO on Nasdaq
Location
New York, NY
Fiscal year end
30 June
Latest financial report
10-Q/A - Q3 2025 - 17 Nov 2025

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 336% % 103%
Quick Ratio 0% %
Debt-to-equity 33% % -62%
Return On Equity -84% % 34%
Return On Assets -63% % 6.8%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 19,654,636 shares 128%
Common Stock, Shares, Outstanding 20,254,599 shares 134%
Entity Public Float $22,429,069 USD 406%
Common Stock, Value, Issued $20,000 USD 122%
Weighted Average Number of Shares Outstanding, Basic 52,981,000 shares 514%
Weighted Average Number of Shares Outstanding, Diluted 52,981,000 shares 514%

Income Statement

Label TTM Value / Value Unit Change %
Revenue from Contract with Customer, Excluding Assessed Tax $500,000 USD
Research and Development Expense $10,557,000 USD 116%
General and Administrative Expense $10,390,000 USD -4.9%
Operating Income (Loss) $20,447,000 USD -31%
Nonoperating Income (Expense) $339,000 USD -73%
Income Tax Expense (Benefit) $0 USD
Net Income (Loss) Attributable to Parent $20,108,000 USD 13%
Earnings Per Share, Basic -1 USD/shares 35%
Earnings Per Share, Diluted -1 USD/shares 35%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value $28,111,000 USD 155%
Cash, Cash Equivalents, and Short-term Investments $6,431,000 USD -34%
Accounts Receivable, after Allowance for Credit Loss, Current $65,000 USD
Inventory, Net $0 USD
Assets, Current $50,772,000 USD 334%
Property, Plant and Equipment, Net $3,210,000 USD -8.6%
Operating Lease, Right-of-Use Asset $1,958,000 USD -4.5%
Intangible Assets, Net (Excluding Goodwill) $6,843,000 USD 28%
Assets $64,155,000 USD 162%
Accounts Payable, Current $2,822,000 USD 230%
Employee-related Liabilities, Current $876,000 USD -44%
Accrued Liabilities, Current $850,000 USD -21%
Contract with Customer, Liability, Current $1,150,000 USD 188%
Liabilities, Current $6,048,000 USD 74%
Operating Lease, Liability, Noncurrent $2,068,000 USD -6%
Liabilities $8,116,000 USD 20%
Accumulated Other Comprehensive Income (Loss), Net of Tax $15,000 USD
Retained Earnings (Accumulated Deficit) $337,944,000 USD -6.3%
Stockholders' Equity Attributable to Parent $56,039,000 USD 216%
Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest $56,039,000 USD 216%
Liabilities and Equity $64,155,000 USD 162%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities $5,665,000 USD -52%
Net Cash Provided by (Used in) Financing Activities $46,705,000 USD
Net Cash Provided by (Used in) Investing Activities $21,493,000 USD -3114%
Common Stock, Shares Authorized 275,000,000 shares 0%
Common Stock, Shares, Issued 20,254,599 shares 134%
Common Stock, Par or Stated Value Per Share 0 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect $19,547,000 USD
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents $28,339,000 USD 152%
Interest Paid, Excluding Capitalized Interest, Operating Activities $36,000 USD -37%
Deferred Tax Assets, Valuation Allowance $63,392,000 USD 16%
Depreciation $123,000 USD 2.5%
Payments to Acquire Property, Plant, and Equipment $32,000 USD
Lessee, Operating Lease, Liability, to be Paid $3,006,000 USD -18%
Property, Plant and Equipment, Gross $4,828,000 USD 4%
Operating Lease, Liability, Current $504,000 USD 2.9%
Lessee, Operating Lease, Liability, to be Paid, Year Two $693,000 USD 2.8%
Lessee, Operating Lease, Liability, to be Paid, Year One $674,000 USD 3.2%
Operating Lease, Weighted Average Discount Rate, Percent 0.07 pure 0%
Lessee, Operating Lease, Liability, to be Paid, Year Three $715,000 USD 3.2%
Deferred Tax Assets, Operating Loss Carryforwards $56,052,000 USD 14%
Preferred Stock, Shares Issued 0 shares
Preferred Stock, Shares Authorized 1,000,000 shares 0%
Unrecognized Tax Benefits $0 USD
Lessee, Operating Lease, Liability, to be Paid, Year Four $735,000 USD 2.8%
Operating Lease, Payments $141,000 USD 0%
Preferred Stock, Shares Outstanding 0 shares
Amortization of Intangible Assets $20,000 USD 0%
Share-based Payment Arrangement, Expense $1,438,000 USD -12%
Interest Expense $52,000 USD 49%
Preferred Stock, Par or Stated Value Per Share 0 USD/shares 0%